AOTMiT: Transparency Council will address cytomegalovirus and chronic lymphocytic leukemia, among others

The agenda includes:

1. "Determination of total serum calcium concentration. ICD9:077: O77"

Decision problem: preparing a position on the appropriateness of qualifying a health care service as a guaranteed benefit (Article 31c)

2.Livtencity (maribavirum) under the drug program "Treatment of patients with unresponsive or refractory cytomegalovirus (CMV) infection (ICD-10: B25.0, B25.1, B25.8, B25.9)"

Decision-making problem: preparing a position on technology reimbursement (Article 35)

3.Calquence (acalabrutinibum) under PL B.79 "Treatment of patients with chronic lymphocytic leukemia (ICD-10: C91.1)"

Decision-making problem: preparing a position on technology reimbursement (Article 35)

Source: AOTMIT